Prevention of ER-negative breast cancer

被引：0
|
作者：
Brown, P. H. [1 ,2 ]
机构：
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1359-6349(08)70214-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S22
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [21] ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling
    Hutchinson, Samantha A.
    Lianto, Priscilia
    Roberg-Larsen, Hanne
    Battaglia, Sebastiano
    Hughes, Thomas A.
    Thorne, James L.
    NUTRIENTS, 2019, 11 (11)
  • [22] AgNOR analysis of ER-positive and ER-negative tumor cells in breast cancer
    Guski, E
    Winzer, KJ
    Hufnagl, P
    Günther, L
    Kaufmann, O
    PROCEEDINGS OF THE GERMAN SOCIETY FOR PATHOLOGY 82ND MEETING - 1998: SOFT TISSUE TUMORS, 1998, : 470 - 470
  • [23] Estradiol increases ER-negative breast cancer metastasis in an experimental model
    Xujuan Yang
    Aashvini Belosay
    Mengyuan Du
    Timothy M. Fan
    Russell T. Turner
    Urszula T. Iwaniec
    William G. Helferich
    Clinical & Experimental Metastasis, 2013, 30 : 711 - 721
  • [24] Significance of PELP1 in ER-Negative Breast Cancer Metastasis
    Roy, Sudipa
    Chakravarty, Dimple
    Cortez, Valerie
    De Mukhopadhyay, Keya
    Bandyopadhyay, Abhik
    Ahn, Jung-Mo
    Raj, Ganesh V.
    Tekmal, Rajeshwar R.
    Sun, LuZhe
    Vadlamudi, Ratna K.
    MOLECULAR CANCER RESEARCH, 2012, 10 (01) : 25 - 33
  • [25] Estradiol increases ER-negative breast cancer metastasis in an experimental model
    Yang, Xujuan
    Belosay, Aashvini
    Du, Mengyuan
    Fan, Timothy M.
    Turner, Russell T.
    Iwaniec, Urszula T.
    Helferich, William G.
    CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (06) : 711 - 721
  • [26] Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer
    Einefors, Rickard
    Kogler, Ulrika
    Ellberg, Carolina
    Olsson, Hakan
    SPRINGERPLUS, 2013, 2 : 1 - 10
  • [27] Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
    Paolo Peterlongo
    Gisella Figlioli
    Andrew J. Deans
    Fergus J. Couch
    npj Breast Cancer, 7
  • [28] Interleukin-8 in progression of ER-positive and ER-negative breast cancer patients
    Todorovic-Rakovic, N.
    Milovanovic, J.
    Abu Rabi, Z.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S115 - S115
  • [29] Selective cytotoxicity of ascochlorin in ER-negative human breast cancer cell lines
    Sakaguchi, K
    Nakajima, H
    Mizuta, N
    Furukawa, C
    Ozawa, S
    Ando, K
    Chang, YC
    Yamagishi, H
    Magae, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (01) : 46 - 50
  • [30] Hyperactive MAPK dysregulation of microRNAs contributes to the ER-negative phenotype in breast cancer
    Philip, Miller C.
    Lairet, Stephania
    Clarke, Jennifer
    Richer, Jennifer
    El-Ashry, Dorraya
    CANCER RESEARCH, 2012, 72
12345